Prevalence and clinical patterns of epilepsy in children with spastic cerebral palsy: a cross-sectional study in South India
DOI:
https://doi.org/10.18203/2320-6012.ijrms20251758Keywords:
Spastic cerebral palsy, Epilepsy, Seizure type, Quadriplegia, GMFCS, South IndiaAbstract
Background: Cerebral palsy (CP) is frequently accompanied by epilepsy, a comorbidity that exacerbates motor and cognitive impairment. Among the CP subtypes, spastic CP exhibited the highest association with seizures. However, the prevalence and clinical patterns of epilepsy in these children, particularly in the Indian context, remain under-characterized. Objective was to determine the prevalence and characterize the clinical patterns of epilepsy among children with spastic CP in a tertiary care setting in South India.
Methods: This cross-sectional study was conducted over 18 months in the pediatric department of a tertiary hospital. A total of 218 children aged 2-14 years with spastic CP were recruited. Epilepsy diagnosis and seizure types were confirmed using ILAE criteria through clinical history and caregiver interviews. Gross motor function was assessed using the gross motor function classification system (GMFCS). Statistical associations were evaluated using chi-square tests and odds ratios (OR) with 95% confidence intervals (CI).
Results: Epilepsy was prevalent in 52.2% of the patients. The most common type of seizure was tonic-clonic (31.3%), followed by myoclonic (9.6%) and complex partial seizures (8.7%). Children with quadriplegic (36.5%) and diplegic (35.7%) CP exhibited a higher epilepsy prevalence. Epilepsy was most frequent in GMFCS levels II and III. No significant sex differences were observed.
Conclusions: Epilepsy is common in children with spastic CP, particularly among those with quadriplegia, diplegia, and moderate-to-severe motor impairment. Early neurological surveillance and risk-based screening, especially among patients with GMFCS II-IV, may improve detection and long-term outcomes.
Metrics
References
Schoeler NE, Marston L, Lyons L, Halsall S, Jain R, Titre-Johnson S, et al. Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trial. Lancet Neurol. 2023;22(12):1113–24. DOI: https://doi.org/10.1016/S1474-4422(23)00370-8
Ryan JM, Albairami F, Hamilton T, Cope N, Amirmudin NA, Manikandan M, et al. Prevalence and incidence of chronic conditions among adults with cerebral palsy: A systematic review and meta-analysis. Dev Med Child Neurol. 2023;65(9):1174-89. DOI: https://doi.org/10.1111/dmcn.15526
Janas AM, Barry M, Lee S. Epidemiology, causes, and morbidities of stroke in the young. Curr Opin Pediatr. 2023;35(6):641-7. DOI: https://doi.org/10.1097/MOP.0000000000001294
Knight EMP, Amin S, Bahi-Buisson N, Benke TA, Cross JH, Demarest ST, et al. Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial. Lancet Neurol. 2022;21(5):417-27. DOI: https://doi.org/10.1016/S1474-4422(22)00077-1
Glass HC, Soul JS, Chang T, Wusthoff CJ, Chu CJ, Massey SL, et al. Safety of Early Discontinuation of Antiseizure Medication after Acute Symptomatic Neonatal Seizures. JAMA Neurol. 2021;78(7):817-25. DOI: https://doi.org/10.1001/jamaneurol.2021.1437
Symonds JD, Zuberi SM, Stewart K, McLellan A, O’Regan M, MacLeod S, et al. Incidence and phenotypes of childhood-onset genetic epilepsies: A prospective population-based national cohort. Brain. 2019;142(8):2303-18. DOI: https://doi.org/10.1093/brain/awz195
Graham HK, Rosenbaum P, Paneth N, Dan B, Lin JP, Damiano DL, et al. Cerebral palsy. Nat Rev Dis Primers. 2016;2:15082. DOI: https://doi.org/10.1038/nrdp.2015.82
Rattani A, Lim J, Mistry AM, Prablek MA, Roth SG, Jordan LC, et al. Incidence of Epilepsy and Associated Risk Factors in Perinatal Ischemic Stroke Survivors. Pediatr Neurol. 2019;90:44-55. DOI: https://doi.org/10.1016/j.pediatrneurol.2018.08.025
Gururaj AK, Sztriha L, Bener A, Dawodu A, Eapen V. Epilepsy in children with cerebral palsy. Seizure. 2003;12(2):110-4. DOI: https://doi.org/10.1016/S1059131102002558
Zafeiriou DI, Kontopoulos EE, Tsikoulas I. Characteristics and prognosis of epilepsy in children with cerebral palsy. J Child Neurol. 1999;14(5):289-94. DOI: https://doi.org/10.1177/088307389901400504
Sellier E, Platt MJ, Andersen GL, Krägeloh-Mann I, De La Cruz J, Cans C, et al. Decreasing prevalence in cerebral palsy: a multi-site European population-based study, 1980 to 2003. Dev Med Child Neurol. 2016;58(1):85-92. DOI: https://doi.org/10.1111/dmcn.12865
Wallace SJ. Epilepsy in cerebral palsy. Dev Med Child Neurol. 2001;43(10):713. DOI: https://doi.org/10.1017/S0012162201001281
Kwong KL, Wong SN, So KT. Epilepsy in children with cerebral palsy. Pediatr Neurol. 1998;19(1):31-6. DOI: https://doi.org/10.1016/S0887-8994(98)00011-3
Singhi P, Jagirdar S, Khandelwal N, Malhi P. Epilepsy in children with cerebral palsy. J Child Neurol. 2003;18(3):174-9. DOI: https://doi.org/10.1177/08830738030180030601